Clinical Trial Update: Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating nebulized 5% hypertonic saline for bronchiolitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Nebulized 5% Hypertonic Saline (Hypertonic saline 5% for inhalation)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Bronchiolitis | Phase 4 | Status: COMPLETED